Warfarin Sodium
68 NDCs across 4 manufacturers|68 Generic,0 Brand
Warfarin Sodium is used to treat atrial fibrillation, postoperative complications, pulmonary embolism, stroke, thromboembolism and thrombophlebitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Aug 17, 1982. FDA's Orange Book lists 54 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $47 million on Warfarin Sodium across 5.0 million claims for 937,000 beneficiaries.
Warfarin Sodium is available as 68 NDCs from 4 manufacturers (68 generic, 0 brand), with NADAC prices from $0.08 to $0.11 per EA — a 32% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
68
68G / 0B
Manufacturers
4
competing in market
Price Spread
$0.08 – $0.11
per EA
7d Activity
avg +3.7% WoW · of 68 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Upsher-Smith Laboratories LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Vitamin K Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing WARFARIN SODIUM(1 pricing outlier)
Frequently Asked Questions
What is Warfarin Sodium used to treat?
Warfarin Sodium is used to treat atrial fibrillation, postoperative complications, pulmonary embolism, stroke, thromboembolism and thrombophlebitis, per the National Library of Medicine's MED-RT classification.
When did Warfarin Sodium become available as a generic?
FDA approved the first generic Warfarin Sodium (ANDA) on Aug 17, 1982. The Orange Book currently lists 54 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Warfarin Sodium?
In 2024, Medicare Part D spent $47 million on Warfarin Sodium across 5.0 million claims for 937,000 beneficiaries.
How many Warfarin Sodium products are on the market?
The Warfarin Sodium drug market contains 68 NDCs from 4 manufacturers — 68 generic and 0 brand products.
What is the price range for Warfarin Sodium?
NADAC reference prices for Warfarin Sodium range from $0.0813 to $0.1077 per EA — a 32% difference between cheapest and most expensive.
Which manufacturers make Warfarin Sodium?
4 manufacturers list Warfarin Sodium in NADAC. Ranked by number of NDCs, the largest are Upsher-Smith Laboratories LLC (27), Sun Pharmaceutical Industries Inc. (24), Teva Pharmaceuticals USA Inc. (14), American Health Packaging (3).
How has the price of Warfarin Sodium changed recently?
Over the past 7 days, 56 Warfarin Sodium NDCs rose and 4 fell, with a market-wide average change of +3.7%.